Analyst Ratings for Celldex Therapeutics (CLDX)
CLDX Rating Summary
CLDX Price Target Summary
- Highest: $67.00 (Cantor Fitzgerald)
- Lowest: $34.00 (Goldman Sachs)
- Average: $49.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$49.50 (+57.3%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 87%
Avg. $ Target:
$49.50 (+57.3%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 87%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/20/2026 | Barclays » Updated 5/8/2026 |
Etzer Darout | Upgrade | Overweight (Underweight) |
48.00 (45.00) |
33.86 (31.47) |
-7.06% | Details |
| 3/23/2026 | Wolfe Research | Andy Chen | Upgrade | Outperform (Peerperform) |
44.00 (N/A) |
30.90 (31.47) |
1.84% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
